Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Primary cervical screening with high risk human papillomavirus testing: observational study.

Rebolj M, Rimmer J, Denton K, Tidy J, Mathews C, Ellis K, Smith J, Evans C, Giles T, Frew V, Tyler X, Sargent A, Parker J, Holbrook M, Hunt K, Tidbury P, Levine T, Smith D, Patnick J, Stubbs R, Moss S, Kitchener H.

BMJ. 2019 Feb 6;364:l240. doi: 10.1136/bmj.l240.

2.

Screen-detected and Interval Colorectal Cancers in England: Associations with Lifestyle and other Factors in Women in a Large UK Prospective Cohort.

Blanks R, Pust AB, Alison R, He E, Barnes I, Patnick J, Reeves GK, Floud S, Beral V, Green J.

Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32168. [Epub ahead of print]

PMID:
30694563
3.

Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England.

He E, Alison R, Blanks R, Pirie K, Reeves G, Ward RL, Steele R, Patnick J, Canfell K, Beral V, Green J.

Int J Epidemiol. 2019 Jan 21. doi: 10.1093/ije/dyy271. [Epub ahead of print]

PMID:
30668711
4.

Impact of Digital Mammography on Cancer Detection and Recall Rates: 11.3 Million Screening Episodes in the English National Health Service Breast Cancer Screening Program.

Blanks RG, Wallis MG, Alison R, Kearins O, Jenkins J, Patnick J, Given-Wilson RM.

Radiology. 2018 Dec 11:181426. doi: 10.1148/radiol.2018181426. [Epub ahead of print]

PMID:
30526360
5.

Development of an evidence-based brief 'talking' intervention for non-responders to bowel screening for use in primary care: stakeholder interviews.

Cavers D, Calanzani N, Orbell S, Vojt G, Steele RJC, Brownlee L, Smith S, Patnick J, Weller D, Campbell C.

BMC Fam Pract. 2018 Jun 30;19(1):105. doi: 10.1186/s12875-018-0794-6.

6.

The contribution of a negative colorectal screening test result to symptom appraisal and help-seeking behaviour among patients subsequently diagnosed with an interval colorectal cancer.

Barnett KN, Weller D, Smith S, Steele RJ, Vedsted P, Orbell S, Moss SM, Melia JW, Patnick J, Campbell C.

Health Expect. 2018 Aug;21(4):764-773. doi: 10.1111/hex.12672. Epub 2018 Feb 19.

7.

Is an opportunistic primary care-based intervention for non-responders to bowel screening feasible and acceptable? A mixed-methods feasibility study in Scotland.

Calanzani N, Cavers D, Vojt G, Orbell S, Steele RJC, Brownlee L, Smith S, Patnick J, Weller D, Campbell C.

BMJ Open. 2017 Oct 11;7(10):e016307. doi: 10.1136/bmjopen-2017-016307.

8.

Evaluation of a prediction model for colorectal cancer: retrospective analysis of 2.5 million patient records.

Birks J, Bankhead C, Holt TA, Fuller A, Patnick J.

Cancer Med. 2017 Oct;6(10):2453-2460. doi: 10.1002/cam4.1183. Epub 2017 Sep 21.

9.

Promoting early presentation of breast cancer in older women: sustained effect of an intervention to promote breast cancer awareness in routine clinical practice.

Dodd RH, Forster AS, Sellars S, Patnick J, Ramirez AJ, Forbes LJL.

BMC Health Serv Res. 2017 Jun 5;17(1):386. doi: 10.1186/s12913-017-2335-8.

10.

Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial.

Allgood PC, Maroni R, Hudson S, Offman J, Turnbull AE, Peacock L, Steel J, Kirby G, Ingram CE, Somers J, Fuller C, Threlfall AG, Gabe R, Maxwell AJ, Patnick J, Duffy SW.

Lancet Oncol. 2017 Jul;18(7):972-980. doi: 10.1016/S1470-2045(17)30340-6. Epub 2017 May 15.

11.

Psychological Impact of Primary Screening (PIPS) for HPV: a protocol for a cross-sectional evaluation within the NHS cervical screening programme.

McBride E, Marlow L, Forster AS, Moss S, Myles J, Kitchener H, Patnick J, Waller J.

BMJ Open. 2016 Dec 23;6(12):e014356. doi: 10.1136/bmjopen-2016-014356.

12.

Recommendations From the International Colorectal Cancer Screening Network on the Evaluation of the Cost of Screening Programs.

Subramanian S, Tangka FK, Hoover S, Nadel M, Smith R, Atkin W, Patnick J; International Colorectal Cancer Screening Network.

J Public Health Manag Pract. 2016 Sep-Oct;22(5):461-5. doi: 10.1097/PHH.0000000000000386.

13.

Understanding of a negative bowel screening result and potential impact on future symptom appraisal and help-seeking behaviour: a focus group study.

Barnett KN, Weller D, Smith S, Orbell S, Vedsted P, Steele RJC, Melia JW, Moss SM, Patnick J, Campbell C.

Health Expect. 2017 Aug;20(4):584-592. doi: 10.1111/hex.12484. Epub 2016 Jul 14.

14.

A prospective study of anal cancer screening in HIV-positive and negative MSM.

Schofield AM, Sadler L, Nelson L, Gittins M, Desai M, Sargent A, McMahon RF, Hill J, Crosbie EJ, Patnick J, Kitchener HC.

AIDS. 2016 Jun 1;30(9):1375-83. doi: 10.1097/QAD.0000000000001045.

PMID:
26836788
15.

A randomised trial of the effect of postal reminders on attendance for breast screening.

Allgood PC, Maxwell AJ, Hudson S, Offman J, Hutchison G, Beattie C, Tuano-Donnelly R, Threlfall A, Summersgill T, Bellis L, Robinson C, Heaton S, Patnick J, Duffy SW.

Br J Cancer. 2016 Jan 19;114(2):171-6. doi: 10.1038/bjc.2015.451.

16.

Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm.

Kearns B, Whyte S, Seaman HE, Snowball J, Halloran SP, Butler P, Patnick J, Nickerson C, Chilcott J.

Br J Cancer. 2016 Feb 2;114(3):327-33. doi: 10.1038/bjc.2015.469. Epub 2016 Jan 14.

17.

Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.

Duffy SW, Dibden A, Michalopoulos D, Offman J, Parmar D, Jenkins J, Collins B, Robson T, Scorfield S, Green K, Hall C, Liao XH, Ryan M, Johnson F, Stevens G, Kearins O, Sellars S, Patnick J.

Lancet Oncol. 2016 Jan;17(1):109-14. doi: 10.1016/S1470-2045(15)00446-5. Epub 2015 Dec 5. Erratum in: Lancet Oncol. 2016 Feb;17(2):e46.

18.

A qualitative study to assess the potential of the human papillomavirus vaccination programme to encourage under-screened mothers to attend for cervical screening.

Spencer AM, Brabin L, Roberts SA, Patnick J, Elton P, Verma A.

J Fam Plann Reprod Health Care. 2016 Apr;42(2):119-26. doi: 10.1136/jfprhc-2015-101283. Epub 2015 Nov 20.

PMID:
26590048
19.

Effect of Human Papillomavirus vaccination of daughters on the cervical screening uptake of their non-vaccinated mothers.

Spencer AM, Roberts SA, Verma A, Patnick J, Elton P, Brabin L.

Eur J Public Health. 2015 Dec;25(6):1097-100. doi: 10.1093/eurpub/ckv146. Epub 2015 Aug 7.

PMID:
26254459
20.

European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk.

Schüz J, Espina C, Villain P, Herrero R, Leon ME, Minozzi S, Romieu I, Segnan N, Wardle J, Wiseman M, Belardelli F, Bettcher D, Cavalli F, Galea G, Lenoir G, Martin-Moreno JM, Nicula FA, Olsen JH, Patnick J, Primic-Zakelj M, Puska P, van Leeuwen FE, Wiestler O, Zatonski W; Working Groups of Scientific Experts.

Cancer Epidemiol. 2015 Dec;39 Suppl 1:S1-10. doi: 10.1016/j.canep.2015.05.009. Epub 2015 Jul 9.

21.

Evaluation of colonoscopy performance based on post-procedure bleeding complications: application of procedure complexity-adjusted model.

Blanks RG, Nickerson C, Patnick J, Rees C, Rutter M.

Endoscopy. 2015 Oct;47(10):910-6. doi: 10.1055/s-0034-1392263. Epub 2015 Jun 12.

PMID:
26070007
22.

Participation rates for organized colorectal cancer screening programmes: an international comparison.

Klabunde C, Blom J, Bulliard JL, Garcia M, Hagoel L, Mai V, Patnick J, Rozjabek H, Senore C, Törnberg S.

J Med Screen. 2015 Sep;22(3):119-26. doi: 10.1177/0969141315584694. Epub 2015 May 12.

PMID:
25967088
23.

Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study.

Castanon A, Landy R, Brocklehurst P, Evans H, Peebles D, Singh N, Walker P, Patnick J, Sasieni P; PaCT Study Group.

BMJ. 2014 Nov 5;349:g6223. doi: 10.1136/bmj.g6223. Erratum in: BMJ. 2014;349:g7406. Chin, S [corrected to China, S].

24.

Implementing a national flexible sigmoidoscopy screening program: results of the English early pilot.

Bevan R, Rubin G, Sofianopoulou E, Patnick J, Rees CJ.

Endoscopy. 2015 Mar;47(3):225-31. doi: 10.1055/s-0034-1378119. Epub 2014 Sep 30.

PMID:
25268309
25.

Delays in diagnosis of young females with symptomatic cervical cancer in England: an interview-based study.

Lim AW, Ramirez AJ, Hamilton W, Sasieni P, Patnick J, Forbes LJ.

Br J Gen Pract. 2014 Oct;64(627):e602-10. doi: 10.3399/bjgp14X681757.

26.

Interventions to improve cervical cancer screening uptake amongst young women: a systematic review.

Albrow R, Blomberg K, Kitchener H, Brabin L, Patnick J, Tishelman C, Törnberg S, Sparén P, Widmark C.

Acta Oncol. 2014 Apr;53(4):445-51. doi: 10.3109/0284186X.2013.869618. Epub 2014 Feb 7. Review.

PMID:
24660768
27.

Sociodemographic factors predicting mother's cervical screening and daughter's HPV vaccination uptake.

Spencer AM, Roberts SA, Brabin L, Patnick J, Verma A.

J Epidemiol Community Health. 2014 Jun;68(6):571-7. doi: 10.1136/jech-2013-202629. Epub 2014 Feb 24.

PMID:
24567443
28.

Risk factors for adverse events related to polypectomy in the English Bowel Cancer Screening Programme.

Rutter MD, Nickerson C, Rees CJ, Patnick J, Blanks RG.

Endoscopy. 2014 Feb;46(2):90-7. doi: 10.1055/s-0033-1344987. Epub 2014 Jan 29.

PMID:
24477363
29.

Colonoscopic factors associated with adenoma detection in a national colorectal cancer screening program.

Lee TJ, Rees CJ, Blanks RG, Moss SM, Nickerson C, Wright KC, James PW, McNally RJ, Patnick J, Rutter MD.

Endoscopy. 2014 Mar;46(3):203-11. doi: 10.1055/s-0033-1358831. Epub 2014 Jan 28.

30.

Use of research questionnaires in the NHS Bowel Cancer Screening Programme in England: impact on screening uptake.

Watson J, Shaw K, Macgregor M, Smith S, Halloran S, Patnick J, Beral V, Green J; Bowel Screening Follow-up Study Investigators and Collaborators.

J Med Screen. 2013 Dec;20(4):192-7. doi: 10.1177/0969141313511447. Epub 2013 Oct 31.

PMID:
24177175
31.

Surgeon and breast unit volume-outcome relationships in breast cancer surgery and treatment.

McDermott AM, Wall DM, Waters PS, Cheung S, Sibbering M, Horgan K, Kearins O, Lawrence G, Patnick J, Kerin MJ; ABS Audit Committee.

Ann Surg. 2013 Nov;258(5):808-13; discussion 813-4. doi: 10.1097/SLA.0b013e3182a66eb0.

PMID:
23989053
32.

Use of CT colonography in the English Bowel Cancer Screening Programme.

Plumb AA, Halligan S, Nickerson C, Bassett P, Goddard AF, Taylor SA, Patnick J, Burling D.

Gut. 2014 Jun;63(6):964-73. doi: 10.1136/gutjnl-2013-304697. Epub 2013 Aug 16.

33.

Benefits of cancer screening take years to appreciate.

Patnick J.

BMJ. 2013 Jan 16;346:f299. doi: 10.1136/bmj.f299. No abstract available.

PMID:
23325877
34.

The Jade Goody Effect: whose cervical screening decisions were influenced by her story?

Marlow LA, Sangha A, Patnick J, Waller J.

J Med Screen. 2012 Dec;19(4):184-8. doi: 10.1258/jms.2012.012095. Epub 2012 Dec 27.

PMID:
23271834
35.

Cervical screening uptake, political interest and voter turnout: a population-based survey of women in England.

Macedo A, Waller J, Patnick J, Marlow L.

J Med Screen. 2012 Dec;19(4):189-94. doi: 10.1258/jms.2012.012073. Epub 2012 Dec 21.

PMID:
23264650
36.

Promoting early presentation of breast cancer in older women: implementing an evidence-based intervention in routine clinical practice.

Forbes LJ, Forster AS, Dodd RH, Tucker L, Laming R, Sellars S, Patnick J, Ramirez AJ.

J Cancer Epidemiol. 2012;2012:835167. doi: 10.1155/2012/835167. Epub 2012 Nov 7.

37.

Communicating the balance sheet in breast cancer screening.

Giordano L, Cogo C, Patnick J, Paci E; Euroscreen Working Group.

J Med Screen. 2012;19 Suppl 1:67-71.

PMID:
22972812
38.

False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.

Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, Giordano L, Frigerio A, Törnberg S; EUNICE Project and Euroscreen Working Groups, Van Hal G, Martens P, Májek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Péntek Z, Budai A, Mádai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sánchez-Contador Escudero C, Zubizarreta Alberti R, Fernández Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibáñez Cabanell J, Wiege M, Ohlsson G, Törnberg S, Korzeniewska M, de Wolf C, Fracheboud J, Patnick J, Lancucki L, Ducarroz S, Suonio E.

J Med Screen. 2012;19 Suppl 1:57-66. Review.

PMID:
22972811
39.

Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study.

Legood R, Smith M, Lew JB, Walker R, Moss S, Kitchener H, Patnick J, Canfell K.

BMJ. 2012 Oct 31;345:e7086. doi: 10.1136/bmj.e7086.

40.

Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study.

Castanon A, Brocklehurst P, Evans H, Peebles D, Singh N, Walker P, Patnick J, Sasieni P; PaCT Study Group.

BMJ. 2012 Aug 16;345:e5174. doi: 10.1136/bmj.e5174.

41.

Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.

Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C; English Bowel Cancer Screening Evaluation Committee.

Gut. 2012 Oct;61(10):1439-46. Epub 2011 Dec 7.

42.

Effect of population-based screening on breast cancer mortality.

Bock K, Borisch B, Cawson J, Damtjernhaug B, de Wolf C, Dean P, den Heeten A, Doyle G, Fox R, Frigerio A, Gilbert F, Hecht G, Heindel W, Heywang-Köbrunner SH, Holland R, Jones F, Lernevall A, Madai S, Mairs A, Muller J, Nisbet P, O'Doherty A, Patnick J, Perry N, Regitz-Jedermann L, Rickard M, Rodrigues V, Del Turco MR, Scharpantgen A, Schwartz W, Seradour B, Skaane P, Tabar L, Tornberg S, Ursin G, Van Limbergen E, Vandenbroucke A, Warren LJ, Warwick L, Yaffe M, Zappa M.

Lancet. 2011 Nov 19;378(9805):1775-6. doi: 10.1016/S0140-6736(11)61766-2. No abstract available. Erratum in: Lancet. 2013 Feb 16;381(9866):536.

PMID:
22098846
43.

Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.

Lee TJ, Rutter MD, Blanks RG, Moss SM, Goddard AF, Chilton A, Nickerson C, McNally RJ, Patnick J, Rees CJ.

Gut. 2012 Jul;61(7):1050-7. doi: 10.1136/gutjnl-2011-300651. Epub 2011 Sep 22.

PMID:
21940723
44.

Extending the age range for breast screening in England: pilot study to assess the feasibility and acceptability of randomization.

Moser K, Sellars S, Wheaton M, Cooke J, Duncan A, Maxwell A, Michell M, Wilson M, Beral V, Peto R, Richards M, Patnick J.

J Med Screen. 2011;18(2):96-102. doi: 10.1258/jms.2011.011065.

PMID:
21852703
45.

Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network.

Benson VS, Atkin WS, Green J, Nadel MR, Patnick J, Smith RA, Villain P; International Colorectal Cancer Screening Network.

Int J Cancer. 2012 Jun 15;130(12):2961-73. doi: 10.1002/ijc.26310. Epub 2011 Aug 30.

46.

Avoiding inappropriate invitations to cancer screening programmes: the role of primary care.

Campbell C, Anandan C, Appleton S, Elton R, Patnick J, Weller D.

J Med Screen. 2011;18(1):12-7. doi: 10.1258/jms.2011.009122.

PMID:
21536811
47.

Women's preferences for the delivery of the National Health Service Breast Screening Programme: a cross-sectional survey.

Linsell L, Forbes LJ, Patnick J, Wardle J, Austoker J, Ramirez AJ.

J Med Screen. 2010;17(4):176-80. doi: 10.1258/jms.2010.010037.

PMID:
21258127
48.

Clinicians' concerns about decision support interventions for patients facing breast cancer surgery options: understanding the challenge of implementing shared decision-making.

Caldon LJ, Collins KA, Reed MW, Sivell S, Austoker J, Clements AM, Patnick J, Elwyn G; BresDex Group.

Health Expect. 2011 Jun;14(2):133-46. doi: 10.1111/j.1369-7625.2010.00633.x. Epub 2010 Oct 28.

49.

Improving colorectal cancer screening outcomes: proceedings of the second meeting of the International Colorectal Cancer Screening Network, a global quality initiative.

Atkin WS, Benson VS, Green J, Monk CR, Nadel MR, Patnick J, Smith RA, Villain P.

J Med Screen. 2010;17(3):152-7. doi: 10.1258/jms.2010.010002.

PMID:
20956726
50.

Breast and cervical cancer screening programme implementation in 16 countries.

Dowling EC, Klabunde C, Patnick J, Ballard-Barbash R; International Cancer Screening Network (ICSN).

J Med Screen. 2010;17(3):139-46. doi: 10.1258/jms.2010.010033.

PMID:
20956724

Supplemental Content

Loading ...
Support Center